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Review
Extensive literature exists on the use and 
  interpretation of neurodevelopmental tests that 
serve as outcome measures in population stud-
ies examining effects of environ  mental expo-
sures. However, conclusions about the presence 
or absence of a causal relation between an 
exposure to a specific toxicant and a particu-
lar outcome are generally based on weight of 
evidence (WOE), because even well-designed 
studies are subject to methodologic limitations 
that are unavoidable in observational research; 
no single study can be considered sufficient 
for producing definitive results. For this rea-
son, it is crucial that the scientific and regula-
tory communities are able to evaluate findings 
across studies before rendering the WOE-
based conclusions. The term “WOE” has sev-
eral possible definitions; we refer to WOE as 
a methodology with a “simple premise: that 
all available evidence should be examined and 
interpreted” (Weed 2005). It is important to 
clarify that for the purposes of this review we 
focus on weight of epidemiologic (vs., e.g., 
toxicologic) evidence. Such WOE evaluation 
is possible only if the studies under review use 
the same or similar methods of exposure assess-
ment,   outcome ascertainment, data analysis, 
and reporting of results.
To provide a methodologic framework 
for a review of the association between 
in utero and early-life exposures to environ-
mental chemicals and neuro  developmental 
outcomes in children, we considered epide-
miologic studies that focused on prenatal and 
neonatal exposure to polychlorinated biphe-
nyls (PCBs). Our selection of PCBs as the 
exemplar chemical class was based on two 
main considerations. First, it was impor-
tant to select an environmental chemical or 
chemical class for which a sufficient body of 
peer-reviewed literature was available for eval-
uation. Scientific studies on PCBs and neuro-
development date back to the early 1980s 
and include cohorts from several countries. 
Second, for the purposes of this examination 
of neuro  developmental epidemiologic studies 
and implications for interstudy comparison, 
we sought to select a chemical or chemical 
class for which substantial uncertainty exists 
regarding presence or absence of a causal rela-
tion between prenatal/neo  natal exposure and 
neuro  developmental outcomes. With respect 
to PCBs, recent reviews appear to indicate 
considerable disagreement among experts 
(Boucher et al. 2009; Cicchetti et al. 2004; 
Kimbrough and Krouskas 2003; Schantz et al. 
2003), and controversy exists as to whether 
PCBs at current environmental levels of 
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Ba c k g r o u n d: Epidemiologic weight-of-evidence reviews to support regulatory decision making 
regarding the association between environmental chemical exposures and neurodevelopmental out-
comes in children are often complicated by lack of consistency across studies.
oB j e c t i v e: We examined prospective cohort studies evaluating the relation between prenatal and 
neo  natal exposure to polychlorinated biphenyls (PCBs) and neurodevelopment in children to assess 
the feasibility of conducting a meta-analysis to support decision making.
da t a e x t r a c t i o n/synthesis: We described studies in terms of exposure and end point categoriza-
tion, statistical analysis, and reporting of results. We used this evaluation to assess the feasibility of 
grouping studies into reasonably uniform categories.
re s u l t s: The current literature includes 11 cohorts of children for whom effects from prenatal 
or neo  natal PCB exposures were assessed. The most consistently used tests included Brazelton’s 
Neonatal Behavioral Assessment Scale, the neurologic optimality score in the neonatal period, the 
Bayley Scales of Infant Development at 5–8 months of age, and the McCarthy Scales of Children’s 
Abilities in 5-year-olds. Despite administering the same tests at similar ages, the studies were too 
dissimilar to allow a meaningful quantitative examination of outcomes across cohorts.
co n c l u s i o n s: These analyses indicate that our ability to conduct weight-of-evidence assessments 
of the epidemiologic literature on neurotoxicants may be limited, even in the presence of multiple 
studies, if the available study methods, data analysis, and reporting lack comparability. Our find-
ings add support to previous calls for establishing consensus standards for the conduct, analysis, 
and reporting of epidemiologic studies in general, and for those evaluating the effects of potential 
neurotoxic exposures in particular.
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exposure are in fact neuro  toxicants (Winneke 
et al. 2003). Although others have provided 
reviews of the   PCB neurodevelopment litera-
ture (Boucher et al. 2009; Kimbrough and 
Krouskas 2003), their value for WOE is weak-
ened by differing and sometimes idio  syncratic 
matching of neuro  developmental assessment 
instruments to putative neuro  developmental 
domains and by a lack of formal assessment of 
consistency across studies addressing the same 
exposure–outcome associations for the same 
or similar study populations.
The purpose of this review is not to 
weigh in on the ongoing debate over neuro-
developmental effects of PCBs. Instead, we 
used studies of PCBs as a vehicle for evalu-
ating the state of the science in population 
research aimed at investigating the relation 
between pre  natal or neonatal exposures to 
environ  mental chemi  cals and performance 
on neuro  developmental function tests. In this 
review, we present results from our assessment 
of the epidemiologic literature on the rela-
tion between PCBs and neuro  development 
regarding a) the consistency of study methods 
with respect to exposure assessment, outcome 
ascertainment, and data analysis; and b) the 
feasibility of conducting a quantitative WOE 
assessment of existing epidemiologic data (i.e., 
a meta-analysis). The goals are to develop a 
general framework for assessing the body of 
evidence in neuro  developmental environmen-
tal epidemiology studies and to offer recom-
mendations to guide future research such that 
results will be more amenable to WOE reviews 
in support of regulatory decision making.
Methods
Identification/selection of studies. We used sev-
eral electronic data sources [PubMed (http://
www.ncbi.nlm.nih.gov/pubmed), Cochrane 
Library (http://www.thecochranelibrary.
com), EMBASE (http://www.embase.com/
home), PsycINFO (http://www.apa.org/pubs/
databases/psycinfo/index.aspx), and Web-of-
Knowledge (http://apps.isiknowledge.com)] 
to conduct the initial literature search, with 
an end date of December 2009. Using key-
words “polychlorinated,” “biphenyls,” “PCB,” 
“PCBs,” “children,” “prenatal,” “neurodevel-
opmental,” and “neurobehavioral,” as well as 
various combinations of these keywords, we 
selected relevant articles that investigated the 
neurodevelopmental effects of environmental 
PCB exposures in children (poisoning events 
were not considered). We reviewed second-
ary references of retrieved articles to identify 
publications not captured by the electronic 
search. We conducted additional literature 
searches to identify relevant reports and text-
book chapters that were not published in the 
peer-reviewed literature.
The prospective longitudinal design pro-
vides the most informative data for examining 
outcomes associated with in utero and early-
life exposures (Amler et al. 2006; Wigle et al. 
2008). For this reason, our search of the lit-
erature focused specifically on cohort studies 
that recruited participants either prenatally or 
soon after birth and linked various measures 
of pre- and postnatal PCB exposures to neu-
rodevelopmental outcomes at different ages; 
at the time of this review, some of the studies 
had conducted only one neurodevelopmental 
evaluation.
Literature review. We retrieved and 
reviewed the publications identified via the 
literature search (~ 60 articles) and extracted 
information on each relevant study with 
respect to its methods of data collection, 
analysis and reporting. Extracted information 
was categorized according to the following 
characteristics: a) cohort description—year of 
enrollment, geographic location, and ages at 
which neurodevelopmental/neurobehavioral 
tests were administered; b) exposure catego-
rization—whether information was based on 
maternal dietary questionnaires or measured 
(e.g., in breast milk, maternal serum, or cord 
blood) and units of measures [e.g., nanograms 
per gram, parts per billion, or toxic equivalents 
(TEQs)]; c) tests used to define the end points 
of interest—neurologic [e.g., neurologic opti-
mality scores (NOSs)], cognitive [e.g., Bayley 
Scales of Infant Development (BSID)], or 
other tests assessing specific domains of func-
tioning; and d) analysis and reporting of 
result—linear regression coefficients with and 
without log transformation of variables, para-
metric or nonparametric comparisons of out-
comes in two or more groups, or qualitative 
description of results.
This characterization of the cohort studies 
allowed us to search for reasonably homoge-
neous groups of articles that could then be 
included in a systematic analysis. Within each 
group, we assessed the feasibility of a meta-
analysis of the published data. It is a common 
practice that a minimum data set needed for 
the systematic analysis should include at least 
three similar studies, in which measures of 
effect and corresponding measures of vari-
ance for the same exposure–outcome asso-
ciation within the same age group either were 
reported by the study authors or could be 
calculated using the data from the original 
articles (Treadwell et al. 2006).
Results
Overview of PCB cohort studies. The current 
published literature includes 11 cohort studies 
of children for whom pre- or neonatal PCB 
exposures were measured (as maternal blood 
levels during pregnancy, cord blood, breast 
milk concentrations, or combinations of these) 
or estimated. These studies represent a wide 
range of populations (in terms of geography 
and year of enrollment) recruited either at birth 
or prenatally, some of which were followed for 
several years (up to 11 years for one cohort). 
Geographically, five of the cohorts were 
recruited in the United States and Canada, 
five in Europe, and one in Japan. The neu-
rodevelopmental outcomes at various ages were 
described in at least 40 different articles with 
publication dates spanning a 26-year interval 
from 1984 through 2009. Figure 1 summarizes 
tests administered in each cohort study at dif-
ferent ages through the seventh year of life. 
[Figure 1 also includes a twelfth cohort—the 
Pregnancy, Infection, and Nutrition Babies 
Study (Pan et al. 2009)—that has reported 
results for only one neurodevelopmental func-
tion testing period to date and used function 
tests that differed from those used for the other 
cohort studies. This cohort is not discussed 
further.] Most (9 of 11) cohorts were evaluated 
for neurologic and behavioral function or cog-
nitive ability during the first year of life. After 
the first year of age, the frequency of testing 
decreased. Importantly, although not shown 
in Figure 1, after 8 years of age the avail-
able neuro  developmental data become even 
more sparse.
Feasibility of quantitative analysis. Our 
review of each cohort summarized in Figure 1 
showed that the opportunities for a WOE 
review and/or meta-analysis of studies that 
used the same tests among children of the 
same or similar age appear to be most promis-
ing in the first and the fifth years of life. As 
noted in “Methods,” our goal was to identify 
reasonably homogeneous groups of at least 
three studies. Studies were considered eligi-
ble for a meta-analysis if a) similar tests were 
administered at similar ages, b) exposure was 
measured and reported in comparable ways, 
c) results represented comparable measures of 
effect, and d) for the purposes of weighting 
in a meta-analysis, measures of effect were 
accompanied by corresponding measures 
of variance.
The earliest opportunity to assess consis-
tency of findings across studies in terms of 
participants’ age was presented in the neo-
natal period (i.e., within 28 days postpartum). 
Studies conducted in the United States and in 
Europe used different types of testing to exam-
ine neurobehavioral function in newborns. 
As shown in Table 1, the three U.S. studies 
included the Michigan cohort (Jacobson et al. 
1984), the Oswego cohort (Lonky et al. 1996; 
Stewart et al. 2000), and the North Carolina 
cohort (Rogan et al. 1986). All of the U.S. 
studies administered Brazelton’s Neonatal 
Behavioral Assessment Scale (NBAS), which 
was divided into seven clusters. Six of those 
clusters—response decrement, orientation, 
tonicity, range of state, regulation of state, 
and autonomic maturity—are considered 
behavioral. One cluster—reflex—is aimed at 
evaluating neurologic function. Meta-analyses and neurotoxicants
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The Michigan and Oswego cohorts were 
given the NBAS test within the first 3 days 
of life. Both studies carried out multivariate 
analyses to link fish consumption (as a sur-
rogate for exposure to PCBs) to NBAS score; 
however, the outcome definitions for the two 
cohorts differed from each other. Specifically, 
the Michigan study (Jacobson et al. 1984) 
used a single NBAS result obtained on the 
third day of life, whereas the Oswego study 
(Lonky et al. 1996) defined the outcome as 
the difference between two assessments con-
ducted in the second and the first day after 
birth. Further, the multivariate analyses in the 
two studies [linear regression for the Michigan 
study and multivariate analysis of covariance 
(MANCOVA) for the Oswego study] pro-
duced results that could not be compared 
and/or combined quantitatively. A second 
publication based on the Oswego cohort 
(Stewart et al. 2000) examined the association 
between NBAS and cord blood PCBs in addi-
tion to fish consumption, which was already 
assessed by Lonky et al. (1996). The exposure 
was assessed using four metrics (total PCBs, 
lightly chlorinated PCBs, moderately chlori-
nated PCBs, and highly chlorinated PCBs), 
and the outcomes in this study were assessed 
separately at each time interval (1 day and 
2 days of life) both as the NBAS score for 
each cluster and as an overall proportion of 
poor scores. The data were analyzed using a 
test for trend statistic; however, the quantita-
tive results were reported only for the sec-
ond day of life assessment and only for highly 
chlorinated PCBs. 
The third study (the North Carolina 
cohort) that administered NBAS did 
so between the first and third week of life 
(Rogan et al. 1986). The analytic approach 
(linear regression) used in the North Carolina 
study was similar to that of the Michigan 
study (Jacobson et al. 1984), but the exposure 
measures differed (PCBs measured in breast 
milk were compared with estimates of PCB 
exposure based on fish consumption informa-
tion or cord blood levels). In addition, the 
results were presented in terms of p-values 
without reporting the regression coefficients. 
Thus, despite the consistent use of NBAS in 
the first week of life by these three cohorts, 
differences in methods for estimating expo-
sures and in reporting of outcomes preclude 
conducting a quantitative systematic review 
across the cohorts. It is worth noting that 
even if the statistical method had been con-
sistent across studies, the differences in choice 
of covariates would still have rendered it very 
difficult to synthesize the effect sizes across 
studies (Lipsey 2001).
The three European studies of neo-
natal outcomes (Table 2) were conducted in 
Duisburg, Germany (Wilhelm et al. 2008), the 
Netherlands (Huisman et al. 1995a), and the 
Faroe Islands (Steuerwald et al. 2000). All three 
studies used the NOS, a combined measure 
that consists of 60 components with an opti-
mal range of results predefined for each item, 
with the final score calculated as the total num-
ber of optimal items (Touwen et al. 1980).
All three of these studies conducted the 
NOS assessment between 1 and 3 weeks of 
life and in that respect are comparable to the 
North Carolina cohort. Two of the three 
European studies—the Duisburg (Wilhelm 
et al. 2008) and Faroe Islands (Steuerwald 
et al. 2000) cohorts—performed linear regres-
sion analyses to examine the relation of NOS 
scores at 2 weeks of life to PCB levels in 
both milk and maternal blood samples; how-
ever, quantitative results are given only for 
Figure 1. Summary of tests used in the PCB cohorts by age (for children up to 7 years of age at follow-up). Collaborative Perinatal Project, USA (Daniels et al. 
2003); Michigan, USA (Jacobson et al. 1984); North Carolina, USA (Rogan et al. 1986); Pregnancy, Infection, and Nutrition Babies Study, USA, (Pan et al. 2009); 
Oswego, USA (Lonky et al. 1996); Nunavik, Canada (Després et al. 2005); Dusseldorf, Germany (Winneke et al. 1998); Duisburg, Germany (Wilhelm et al. 2008); 
Faroe Islands 1 (Grandjean et al. 2001); Faroe Islands 2 (Steuerwald et al. 2000); Groningen/Rotterdam, the Netherlands (Huisman et al. 1995a); Hokkaido, Japan 
(Nakajima et al. 2006). Additional testing was conducted with the Oswego cohort at 8 and 9 years of age, the Netherlands cohort at 9 years of age, and the 
Michigan cohort at 11 years of age.
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the Duisburg cohort (Wilhelm et al. 2008). 
In addition, different analytes were selected 
for exposure assessment in these two stud-
ies. Wilhelm et al. (2008) examined PCBs 
together with polychlorinated dibenzo-p-
  dioxins and dibenzofurans (PCDD/Fs), 
whereas Steuerwald et al. (2000) expressed 
exposure as ΣPCB (the sum of PCB conge-
ners). the Netherlands cohort (Huisman et al. 
1995a) dichotomized the NOS using the 
median PCB concentration in the study pop-
ulation as the cutoff. For the resulting binary 
outcome in the logistic regression analyses, 
the independent variable of interest was the 
log-transformed ΣPCB and various ΣPCB 
subsets (e.g., planar versus nonplanar). Again, 
despite the availability of three studies using 
the same neurodevelopmental test, differences 
in methods for estimating exposures and in 
reporting of outcomes preclude conducting a 
quantitative systematic review.
Six cohort studies used the same test—
BSID—to assess the cognitive function of 
their participants between 5 and 8 months 
of age and thus could provide compa-
rable data (Table 3). Three of these studies 
were conducted in the United States. The 
Table 2. European studies that examined neurologic and behavioral function among newborns using the NOS in relation to meas  ures of prenatal or early-life 
PCB exposure.
Reference, cohort
Age at test 
administration Exposure measure Tests measuring association Results 
Huisman et al. 1995a, 
the Netherlands
10–21 days Individual, Σ, and TEQs: planar PCBs 
(3 congeners) and nonplanar PCBs (up to 
23 congeners) in breast milk fat; individual 
and ΣPCBs (4 congeners) in maternal 
plasma and cord plasma 
Logistic regression with outcome 
dichotomized as optimal vs. nonoptimal 
and results expressed as odds ratios for 
doubling of exposure adjusted for maternal 
age, study center, alcohol use
Reported as odds ratios and 
corresponding 95% confidence 
intervals
Steuerwald et al. 2000, 
Faroe Islands
2 weeks ΣPCBs (three congeners) in breast milk, 
lipid-adjusted ΣPCBs (3 congeners) in 
maternal serum
Linear regression where exposure and 
outcome were expressed as continuous 
variables controlling for Hg and other (not 
specified) covariates
Text indicates weak positive 
association; regression results 
not reported; Spearman’s 
correlation coefficients reported 
(but without variance)
Wilhelm et al. 2008, 
Duisburg, Germany
2 weeks PCDD/F + PCB TEQs (congeners not 
specified) in maternal blood and breast 
milk lipid
Linear regression presented as MD, where 
MD – 1 = β for doubling of exposure 
adjusted for maternal age, gestational 
age, birth weight, alcohol intake, age of 
examination, maternal Pb and Hg exposure, 
and examiner
Reported as linear regression 
coefficients and corresponding 
95% confidence intervals
Abbreviations: Hg, mercury; MD, mean differences; Pb, lead.
Table 1. U.S. studies of neurologic and behavioral function among newborns using the Brazelton NBASa in relation to measures of prenatal/early-life PCB exposure.
Reference, cohort
Age at test 
administration Exposure measure Tests measuring association Results
Jacobson et al. 1984, 
Michigan, USA
3 days Fish consumption as 
surrogate for PCB 
exposure
Chi-square test where outcome is 
dichotomized as normal vs. worrisome 
and exposure is defined as none vs. high
Chi-square test with level of significance (e.g., < 0.1, < 0.05)
Partial correlations adjusted (one at a time) 
for birth weight, head circumference, 
gestational age, and BEFM
Partial correlations (with level of significance, but without 
variance) reported for lability of states (a subset of RaS), 
RaS, AM, and R; other clusters not reported
Multiple linear regression, adjusted 
for birth weight, head circumference, 
gestational age
Regression coefficients (with level of significance, but 
without variance) reported for lability of states, AM and 
R; other clusters not reported
Cord serum PCBs 
(congeners not 
specified)
Linear F-test adjusted for birth weight, 
head circumference, gestational age, and 
BEFM
For cord blood, text indicates no significant association
Rogan et al. 1986, 
North Carolina, 
USA
1–3 weeks PCB in breast milk 
fat (congeners not 
specified)
Multiple linear regression, adjusted 
(simultaneously) for maternal age, 
education, occupation, smoking, drinking, 
fish intake, and anesthesia; infant’s race, 
sex, birth weight, jaundice, age of testing, 
interval between testing and feeding
Results reported as significant for T and R (regression 
coefficients not reported); results for other clusters not 
reported, but text notes significant associations were 
found only for T and R and that for RD p-value was 0.07
Lonky et al. 1996, 
Oswego, New York, 
USAb
1 day and 2 days Fish consumption as 
surrogate for PCB 
exposure
MANCOVA with principal components 
analysis; outcome: the difference between 
two assessments; exposure: three fish 
consumption groups (high, low, and none)
F-values with levels of significance (Bonferroni adjusted) 
reported for six clusters, all except RD; direction/
magnitude of difference reported for R, AM, and RD across 
three levels of fish consumption (but without variance)
Stewart et al. 2000, 
Oswego, New York, 
USA
1 day and 2 days ΣPCB (69 congeners) 
in cord blood; lightly, 
moderately, and 
highly chlorinated 
PCB congeners in 
cord blood; fish 
consumption as 
surrogate for PCB 
exposure
Linear F-test for each age (1 day and 
2 days) analyzed separately across four 
categories of highly chlorinated PCBs 
(nondetectable, low, medium, and high) 
adjusted for unspecified covariates and 
three fish consumption groups (high, low, 
and none); linear F-test across exposure 
categories where outcome is defined as 
percentage of poor NBAS scores
Results for total ΣPCB and lightly and moderately 
chlorinated PCBs not reported; results for highly chlorinated 
PCBs at 1 day noted as showing no differences; results 
for highly chlorinated PCB at 2 days given as linear term 
(F-statistic) for R, AM, and RD with either p-values or 
levels of significance; results for percentage of poor NBAS 
scores given as F-test and a p-value for highly chlorinated 
cord blood PCB and fish consumption; text indicates that 
lightly and moderately chlorinated PCB were not related to 
percentage of poor NBAS scores
BEFM, Ballard Examination for Fetal Maturity.
aBrazelton NBAS clusters: response decrement (RD), orientation, tonicity (T), range of state (RaS), regulation of state (ReS), autonomic maturity (AM), and reflex (R). bNBAS seven 
  clusters administered twice: at 12–25 and 25–48 hr of life.Meta-analyses and neurotoxicants
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Michigan and the North Carolina cohort 
studies (Gladen et al. 1988; Jacobson et al. 
1986) have been discussed previously in the 
context of neonatal assessment. The third 
U.S. study (Daniels et al. 2003) represents a 
multicenter effort—called the Collaborative 
Perinatal Project—that recruited partici-
pants from several sites (Baltimore, MD; 
Boston, MA; Buffalo, NY; Memphis, TN; 
Minneapolis, MN; New Orleans, LA; New 
York, NY; Philadelphia, PA; Portland, OR; 
Providence, RI; Richmond, VA). Among the 
three European studies shown in Table 3, 
two were carried out using the same cohort in 
Dusseldorf, Germany (Walkowiak et al. 2001; 
Winneke et al. 1998), and one was conducted 
using a subset of the previously discussed 
cohort of children from the Netherlands 
(Koopman-Esseboom et al. 1996). One addi-
tional study in this category was performed 
with a cohort of children from Sapporo, Japan 
(the Hokkaido Study on Environment and 
Children’s Health) (Nakajima et al. 2006).
The versions of the BSID assessment used 
in these studies included two main scores: 
the Mental Development Index (MDI) and 
the Psychomotor Development Index (PDI). 
As shown in Table 3, all studies evaluat-
ing the relation between BSID in the first 
year of life and PCB exposure used linear 
regression to estimate the effect. However, 
the reporting and interpretation of the lin-
ear regression coefficients differed across the 
studies. Although we identified four studies 
that examined the relationship between MDI 
and PCB concentrations in maternal or cord 
blood, the results in these studies represented 
different measures of effect. In two of the four 
studies, the regression coefficients represented 
change in MDI per unit of PCB increase 
(micrograms per liter or nanograms per gram) 
(Daniels et al. 2003; Winneke et al. 1998); in 
two other studies (Koopman-Esseboom et al. 
1996; Nakajima et al. 2006), the correspond-
ing coefficients represented change in MDI 
per natural logarithm of exposure. Similarly, 
among the three studies that reported the 
association between MDI and PCBs in breast 
milk, only two (Gladen et al. 1988; Winneke 
et al. 1998) reported their findings as com-
parable regression coefficients per 1 ppm or 
1 ng/g of exposure; the third study (Jacobson 
et al. 1986) simply noted a lack of associa-
tion. Another publication that evaluated the 
relation between breast milk PCB levels and 
MDI (Walkowiak et al. 2001) used the same 
German cohort data as used by Winneke 
et al. (1998) but reported linear regression 
coefficients per logarithm base 2 of exposure. 
The results of studies for PDI at 5–8 months 
of life provided even less comparable informa-
tion. Among the seven publications (based on 
six different cohort studies), only five calcu-
lated and reported regression coefficients, and 
only four of those studies were based on inde-
pendent data. As was the case with MDI, it 
was not possible to identify three independent 
studies that could be combined in a meta-
analysis because of the variability of exposure 
Table 3. Studies using MDI and PDI (BSID) at 5–8 months of age in relation to measures of prenatal or early-life PCB exposure.
Reference, cohort
Age at test 
administration Exposure measure Tests measuring association Results
Jacobson et al. 1986, 
Michigan, USA
5 months Fish consumption as surrogate for 
PCB exposure; cord blood PCBs 
(congeners not specified); breast 
milk PCBs (congeners not specified)
Linear regression and ANCOVA; details not 
reported
Text indicates that no measures of 
exposure were related to MDI or PDI; 
quantitative results not provided
Gladen et al. 1988, 
North Carolina, USA
6 months PCB in breast milk fat (congeners not 
specified) at birth used as measure 
of transplacental exposure; 
estimated cumulative exposure to 
PCB in breast milk (from birth to the 
age of test)
Multiple linear regression per 1 ppm, 
adjusted for maternal age, race, 
education, occupation, smoking, drinking, 
infant’s sex, gestational age, birth weight, 
head circumference, jaundice, duration of 
breast-feeding, number of older siblings, 
abnormal reflexes on NBAS age of 
testing, and center/examiner
Both MDI and PDI results reported 
as regression coefficients, standard 
errors, and two-sided p-values
Koopman-Esseboom 
et al. 1996, the 
Netherlands
7 months Prenatal exposure: ΣPCBs (24 
congeners) in maternal blood drawn 
in the last month of pregnancy; 
postnatal exposure: ΣPCBs (4 
congeners and 24 congeners) in 
breast milk
Multiple linear regression expressed per 
ln(ng/g) adjusted for gestational age, 
parity, HOME score, and duration of 
breast-feeding
Result for MDI reported as regression 
coefficients, standard errors, and 
two-sided p-values; results for PDI not 
reported
Winneke et al. 1998,a 
Dusseldorf, Germany
7 months ΣPCBs (three congeners) in cord 
blood and breast milk
Multiple linear regression expressed 
per ng/g adjusted for maternal age, 
education, vocabulary, smoking and 
drinking, duration of breast-feeding, birth 
weight, HOME score, Apgar score, cord 
blood lead level, and neonatal illness
Both MDI and PDI results for both cord 
blood and breast milk PCB levels 
reported as regression coefficients, 
standard errors, and one-sided 
p-values
Walkowiak et al. 2001,a 
Dusseldorf, Germany
7 months ΣPCBs (three congeners) in breast 
milk and cord serum
Multiple linear regression per log2(ng/g) 
adjusted for parity, smoking, and body 
mass index
For breast milk PCBs, both MDI and 
PDI results reported as regression 
coefficients, standard errors, and one-
sided p-values; for cord blood PCBs, 
text indicates that associations were 
small or positive; quantitative results 
not provided
Daniels et al. 2003, 
Collaborative Perinatal 
Project, USA
8 months ΣPCBs (11 congeners) in maternal 
blood drawn in the third trimester
Multiple linear regression per µg/L 
adjusted for research center, maternal 
education, triglycerides, cholesterol, and 
birth order of the child
Both MDI and PDI results reported 
as regression coefficients, standard 
errors, and two-sided p-values
Nakajima et al. 2006, 
Hokkaido, Japan
6 months ΣPCBs (total 14 congeners and by 
different categories of congeners) 
and TEQs in maternal blood drawn 
in the third trimester of pregnancy 
or after delivery
Multiple linear regression per ln(ng/g) or 
per TEQ adjusted for gestational age, 
smoking and caffeine intake during 
pregnancy, and blood-sampling time
Both MDI and PDI results reported as 
regression coefficients and two-sided 
p-values
HOME, Home Observation for Measurement of the Environment. 
aTwo studies based on the same cohort; Winneke et al. (1998) reported BSID results at 7 months of age only, whereas Walkowiak et al. (2001) evaluated the same subjects again at 18 
and 30 months of age and reported results at all three ages.Goodman et al.
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characterization and/or methods of expressing 
study results. Overall, even with the use of the 
Bayley Scales across several cohorts at similar 
times in life, a quantitative systematic review 
across cohorts was not possible.
Three cohort studies (Michigan, Oswego, 
and Dusseldorf) evaluated their participants 
at 6–7 months of age using the Fagan Test of 
Infant Intelligence. Although all three stud-
ies measured PCB cord blood concentrations 
(among other metrics), the specific conge-
ners were different. Moreover, the association 
between exposure and outcome was assessed 
using different statistical methods: multiple 
linear regression that used PCB levels as a con-
tinuous variable in two studies (Jacobson et al. 
1985 and Winneke et al. 1998) and an F-test 
for trend that used a four-level cord blood 
PCB categorization in the third study (Darvill 
et al. 2000). All three analyses appear to have 
controlled for different sets of confounders. 
Thus, the studies that administered the Fagan 
test were as heterogeneous as the studies that 
used BSID at roughly the same age.
The only remaining opportunity to assess 
the feasibility of conducting a meta-analysis 
was in a group of studies assessing cogni-
tive function during the fifth year of life. As 
shown in Figure 1, three cohort studies in the 
United States (Michigan, Oswego, and North 
Carolina) evaluated the cognitive function 
of their participants between the fourth and 
the fifth birthdays using McCarthy Scales of 
Children’s Abilities and were considered as can-
didates for inclusion in a meta-analysis (Gladen 
and Rogan 1991; Jacobson et al. 1990; Stewart 
et al. 2003). All three of these studies reported 
the results for the General Cognitive Index 
(GCI) of the McCarthy Scales. Only one of 
these studies also presented the results sepa-
rately for the Verbal, Quantitative, Perceptual–
Performance Memory, and Motor Scales 
(Jacobson et al. 1990).
Table 4 summarizes results for the three 
studies evaluating the association between 
perinatal PCB exposure and GCI. It is evi-
dent that despite testing the same hypothe  sis, 
the differences across the three studies were 
too pronounced to allow meaningful conclu-
sions about the presence or absence of con-
sistency in findings. Specifically, although 
the Michigan study (Jacobson et al. 1990) 
conducted linear regression analyses for cord 
blood and breast milk PCB exposures, only 
cord blood results were provided in their pub-
lication. The North Carolina study (Gladen 
and Rogan 1991) used breast milk concentra-
tions to estimate exposure, but the data were 
analyzed using ANCOVA procedures, and 
the quantitative results were not reported. The 
Oswego cohort study (Stewart et al. 2003) 
was similar to the Michigan study in that they 
both estimated exposure based on PCB con-
centration in cord blood. However, unlike the 
Michigan study, the Oswego findings were 
presented not as regression coefficients but as 
linear F-test results, which divided exposure 
into four ordinal categories. As with our other 
attempts at a systematic review across cohorts, 
there was insufficient consistency with expo-
sure measures and outcome reporting to con-
duct such a review.
Discussion
Despite the relatively large body of literature 
on potential associations between early-life 
exposure to PCBs and adverse neurodevel-
opmental effects, controversy still exists over 
whether PCBs are in fact neurotoxicants, and 
to date, the U.S. Environmental Protection 
Agency has not established regulatory guid-
ance values for PCBs based on neurotoxicity. 
Such regulatory decision making generally 
relies on a WOE assessment of studies, which 
in turn requires comparability across stud-
ies. Unfortunately, our examination of the 
PCB neurodevelopmental epidemiology lit-
erature found a lack of interstudy consistency. 
Even for age intervals examined by several 
research groups, presumably testing the same 
hypothesis, a meta-analysis of PCB studies is 
not possible at this time. Moreover, the fre-
quency of evaluations decreased substantially 
and the data became increasingly sparse as the 
cohorts became older. This likely presents a 
missed research opportunity because testing 
in older children may be more reliable, and 
perhaps more informative with respect to the 
long-term prognosis (Sattler 2008). 
As noted above, it is not the purpose of 
this review to weigh in on the ongoing debate 
over neurodevelopmental effects of PCBs, 
but rather to use the PCB neurodevelop-
mental epidemiology literature as the basis 
for describing generalizable issues related to 
interstudy consistency. Replication of find-
ings, often referred to as “repeating a study,” 
is a crucial aspect of the scientific method. 
Ability to repeat or reproduce a result leads 
to generalizable inferences, rather than merely 
to isolated and uncertain findings (Lindsay 
and Ehrenberg 1993). In the field of medical 
research, there is consensus that replication 
(or other substantiation) of clinical trials is a 
requirement for approval of drugs and medi-
cal devices (Berlin and Colditz 1999). Unlike 
testing of drugs and devices, most data gen-
erated by environmental research involving 
human subjects are observational in nature, 
and thus the conditions within a study are far 
less controlled. As noted in a recent review 
(Bellinger 2009), researchers conducting 
observational studies have great latitude in 
how exposure and outcome are measured and 
expressed, which methods for examining asso-
ciations are employed, and which analyses 
among the myriad typically conducted are 
reported. In this regard, the epidemiologic 
studies that rely on neurodevelopmental func-
tion test results as the end points of interest 
may be particularly affected by variability of 
study methods and reporting. This is attrib-
utable to the large number of available test 
batteries, each of which can offer different 
combinations of subtests (Youngstrom et al. 
Table 4. Studies using the GCI of the McCarthy Scales of Children’s Abilities in the fifth year of age in relation to measures of prenatal or early-life PCB exposure.
Reference, cohort
Age at test 
administration Exposure measure Tests measuring association Results
Jacobson et al. 1990, 
Michigan, USA
4 years Cord blood PCBs (congeners not 
specified)
Multiple linear regression per logx(ng/mL) 
+1 adjusted for maternal age, gravidity, 
and examinera
PCB result reported as a regression 
coefficient with a two-sided p-value
Breast milk PCBs (congeners 
not specified)
Details of linear regression modeling for 
breast milk exposure not reported
PCB regression; results not provided
Gladen and Rogan 1991, 
North Carolina, USA
4–5 years PCB (congeners not specified) in 
breast milk fat at birth used as 
a measure of transplacental 
exposure; estimated 
cumulative exposure to PCB in 
breast milk (from birth to the 
age of test)
ANCOVA by dividing transplacental 
exposure into eight categories and 
cumulative breast milk exposure into five 
categories, adjusted for maternal age, 
race, education, occupation, smoking, 
drinking, infant’s sex, number of older 
siblings, feeding pattern
For transplacental PCB exposure text 
indicates no association; quantitative 
results not provided; for cumulative 
breast milk exposure text indicates 
some variation but the pattern “did 
not suggest cause and effect”; 
quantitative results not provided
Stewart et al. 2003, 
Oswego, New York, USA
4.5 years ΣPCBs in cord blood 
(17 congeners)
Linear F-test across four PCB exposure 
categories (nondetectable, low, 
medium, and high) adjusted for various 
combinations of (not specified) covariates
Result reported as a linear term 
without a measure of variance (all 
p-values marked as nonsignificant)
aDetails of log transformation are not given.Meta-analyses and neurotoxicants
Environmental Health Perspectives  •  v o l u m e  118 | n u m b e r 6 | June 2010  733
2010). Even within subtests, there are differ-
ent scales and cutoff points for categorizing 
responses. If these are used and reported selec-
tively, it can be very difficult to determine 
whether two different studies have demon-
strated similar or conflicting results or have 
assessed overlapping but slightly different 
functions (Garabrant 2000).
Although consistency in study methods 
and reporting is a critical prerequisite of any 
WOE review, it is important to stress that 
consistency of methods alone is not sufficient 
for drawing conclusions about causation. 
By combining several studies, meta-analyses 
have an inherent ability to detect relatively 
small statistically significant departures from 
null. However, these relatively precise meta-
estimates may not accurately reflect the true 
association unless the analyses take into con-
sideration potential sources of systematic error 
that may affect reviews of the literature. One 
source of error that warrants consideration 
in any systematic review is publication bias, 
which can occur because studies with statisti-
cally significant positive findings are more 
likely to be published than are studies with 
null results. Publication bias has been shown 
to be of particular importance in observational 
studies (Easterbrook et al. 1991). Another 
closely related concept is selective reporting 
bias within published studies and is defined as 
“selection on the basis of the results of a sub-
set of the original variables recorded for inclu-
sion in a publication” (Dwan et al. 2008). 
Consider, for instance, the Netherlands 
cohort study that administered neurologic 
testing and calculated the NOS at two differ-
ent ages: 10–21 days and 18 months of age 
(Huisman et al. 1995a, 1995b). Although the 
two follow-ups tested the same hypothesis, 
the two statistical analyses were markedly dif-
ferent: logistic regression at 10–21 days and 
linear regression at 18 months of age. Perhaps 
more important, the strongest inverse asso-
ciation (between nonplanar PCBs and NOS) 
observed in newborns does not seem to have 
been reexamined (or at least not reported) in 
the 18-month-olds.
The search for sources of error in any sys-
tematic review inevitably leads to evaluation 
of individual study quality. Issues that need 
to be addressed usually include magnitude of 
nonparticipation or loss to follow-up, misclas-
sification of exposure and/or outcome, and 
ability to control for extraneous factors, all of 
which may introduce bias. For example, an 
important method of minimizing information 
bias is making sure that persons administering 
the test (and at a later age perhaps also subjects 
themselves) are unaware of the participants’ 
exposure status. Among studies summarized 
in this review (Tables 1–4), many indicated 
that they implemented blinding; however, in 
two instances (Gladen et al. 1988; Huisman 
et al. 1995a) the investigators were unaware 
of the results of laboratory analyses but knew 
which children were breast-fed; this informa-
tion was used in estimating PCB exposure. 
In addition, several studies did not mention 
blinding procedures in their respective meth-
ods sections (Daniels et al. 2003; Gladen and 
Rogan 1991; Jacobson et al. 1986; Stewart 
et al. 2003; Wilhelm et al. 2008).
In the absence of comparable published 
information, one potential method for assess-
ing the consistency of findings across stud-
ies would be to obtain the original data and 
then either compare the results using the same 
statistical methods or combine the data in a 
pooled analysis. For example, pooling of the 
data might be helpful in bringing together the 
three studies (Koopman-Esseboom et al. 1996; 
Daniels et al. 2003; Nakajima et al. 2006) 
that examined the association between prena-
tal maternal blood levels of PCBs and BSID 
scores but focused on different sets of conge-
ners, used different modeling approaches, and 
controlled for different covariates. Such pooled 
analyses would be possible for only some of 
the many associations examined to date and 
would, of course, require the cooperation of 
researchers and depend on their willingness 
to share data. Perhaps more important, future 
studies of chemical exposures and neurodevel-
opmental outcomes must build on previous 
research with the aim of facilitating WOE 
assessments. Repeated calls for establishing 
consensus standards for the conduct, analysis, 
and reporting of epidemiologic studies have 
been voiced in a variety of areas of research, 
including those related to the effects of neuro-
toxicant exposures (Bellinger 2009).
WOE assessment is essential to interpret-
ing results of epidemiology studies of neuro-
development and chemical exposure. Yet even 
for chemicals that have been studied for their 
neurotoxicity for decades, there is still contro-
versy over whether WOE is sufficient to state 
unequivocally that they are neurotoxicants, 
or to define the dose–response relationship. 
We used PCBs as a case study to highlight the 
need for improved inter- and intrastudy con-
sistency in the selection of neurodevelopment 
function tests and domains to be evaluated, 
exposure assessment, and/or method of ana-
lyzing/reporting data.
Conclusions
We conclude with the following recommen-
dations: First, although novel approaches for 
assessing neurodevelopment will continue to 
be developed and should be used, it is impor-
tant that future research include measures 
comparable to those used by past research-
ers. The lack of inclusion of comparable 
measures will hinder our ability to conduct 
WOE assessments. We recommend that key 
individuals and international organizations 
determine and establish the specific compara-
ble measures that should be included in each 
study. This is not intended to be a prescrip-
tive list that would limit future investigators’ 
novel approaches, but rather a methodologic 
feature that would permit future evaluations 
by scientists and regulators.
Similarly, future investigators will likely 
have new tools (or a favored tool) for assess-
ing exposure to environmental chemicals. 
These include traditional exposure assess-
ments, biomonitoring, and use of biomarkers 
of exposure. A standard, baseline metric of 
exposure should be derived that is evaluated 
as a minimum exposure metric for all studies 
(other types of exposure assessments could be 
conducted in addition to this baseline metric) 
to again allow for interstudy comparisons.
Third, although efforts are being made 
within certain agencies (e.g., the National 
Institutes of Health) to require sharing of raw 
data, a broader effort is needed to ensure that 
study data are available for WOE assessments. 
This will not occur without in-place require-
ments (i.e., agency-required data sharing) as 
part of research-funding mechanisms.
In addition, selection of statistical meth-
ods for analyzing data from complex data sets 
has been the subject of intense and some-
times acrimonious debate (Kimbrough and 
Krouskas 2003). To this end, we recommend 
that an expert panel composed of statisticians, 
neurologists, psychologists, psychometricians, 
epidemiologists, and exposure and risk asses-
sors from academia and government who have 
not been part of past environmental neuro-
developmental epidemiology studies (and can 
therefore bring fresh perspectives) be convened 
to discuss and recommend best practices.
Last, journals could facilitate progress by 
either accepting or requiring the archival of 
tables of summary statistics, such as unad-
justed correlations, means, and standard devia-
tions, perhaps augmented by a description of 
patterns of missing data. Some publication 
manuals, style guides, and other guidelines 
recommend the archiving of sufficient descrip-
tive statistics to allow independent analyses of 
the data (American Psychological Association 
2010). Techniques are available that would 
allow the inclusion of these summary tables 
in subsequent meta-analyses (Becker 1996), 
and they also would establish a “least common 
denominator” of data reporting that would 
still represent an advance over the current 
fragmented and hard to synthesize state of the 
literature.
We recognize that reaching agreement 
within the scientific community on the recom-
mendations above will be difficult. However, 
we believe that without some consensus on 
each of these issues, our ability to truly evalu-
ate neurodevelopmental risks associated with 
chemical exposures will not be possible.Goodman et al.
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